Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review
- 8 April 2019
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 33 (5) , 431-456
Abstract
Non-adherence to medications is a major determinant of poor outcome in bipolar disorder. Second-generation long-acting injectable (LAI) antipsychotics help ensure medication adherence which in turn can lead to more favourable outcomes. However, the role of these medications in bipolar disorder is not well established.Keywords
This publication has 47 references indexed in Scilit:
- Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar DisorderThe Primary Care Companion For CNS Disorders, 2013
- Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar DisorderCNS Drugs, 2012
- A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar DisorderClinical Neuropharmacology, 2011
- Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptomsBMC Psychiatry, 2011
- A 34-Year-Old Mother with Religious Delusions, Filicidal ThoughtsPsychiatric Annals, 2011
- Long‐acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizersPsychiatry and Clinical Neurosciences, 2011
- Maintenance Electroconvulsive Therapy Combined With Long-Acting Risperidone in the Treatment of Resistant Bipolar Affective DisorderThe Journal of ECT, 2009
- Use of Risperidone Long-Acting Injection to Support Treatment Adherence and Mood Stabilization in Pediatric Bipolar PatientsThe Journal of Clinical Psychiatry, 2009
- Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot studyInternational Journal of Psychiatry in Clinical Practice, 2008
- Risperidone long-acting injection, a promising treatment for patients with bipolar disorderJournal of Mental Health, 2005